Zhao Ming, Discipio Richard G, Wimmer Antonia G, Schraufstatter Ingrid U
Division of Cancer Biology, La Jolla Institute for Molecular Medicine, 4570 Executive Drive, Suite 100, San Diego, CA 92121, USA.
Mol Pharmacol. 2006 Jan;69(1):66-75. doi: 10.1124/mol.105.016923. Epub 2005 Oct 6.
Activation of the chemokine receptor CXCR4 by its agonist stromal cell-derived factor 1 (SDF-1) has been associated with cell migration and proliferation in many cell types, but the intracellular signaling cascades are incompletely defined. Here we show that CXCR4-dependent extracellular signal-regulated kinases 1 and 2 (ERK1/2) phosphorylation was mediated through the Ras/Raf pathway, as demonstrated with a dominant-negative Ras mutant and pharmacological inhibitors. The Src inhibitor 4-amino-5-methylphenyl-7-(t-butyl)pyrazolo[3,4-d] pyrimidine (PP1) and the Rho-kinase (ROCK) inhibitor N-(4-pyridyl)-4-(1-aminoethyl)cyclohexanecarboxamide dihydrochloride (Y27632) also attenuated SDF-1-induced ERK1/2 phosphorylation. Involvement of Src could furthermore be demonstrated by Src phosphorylation and by the shortened ERK1/2 phosphorylation in SYF cells, which are Src/Yes/Fyn-deficient compared with Src-reconstituted Src(++) cells. Membrane translocation of RhoA could be detected similarly. A large portion of the SDF-1-mediated ERK phosphorylation was detected in the nucleus, as shown by Western blotting and confocal microscopy, and resulted in the phosphorylation of the transcription factor Elk. It is interesting that the nuclear accumulation of ERK1/2 and Elk phosphorylation was completely blocked by dominant-negative Rho, Y27632, PP1, and latrunculin B, indicating that the Rho/ROCK pathway, Src kinase, and the actin cytoskeleton were required in this process. In accordance, neither nuclear ERK phosphorylation nor Elk phosphorylation were observed in SYF cells stimulated with SDF-1 but were reconstituted in Src(++) cells. In summary, these results demonstrate that Src, Rho/ROCK, and an intact cytoskeleton contribute to overall ERK1/2 activation in SDF-1-stimulated cells and are indispensable for nuclear translocation of ERK1/2 and activation of transcription factors.
趋化因子受体CXCR4被其激动剂基质细胞衍生因子1(SDF-1)激活,这与多种细胞类型的细胞迁移和增殖有关,但细胞内信号级联反应尚未完全明确。在此我们表明,CXCR4依赖的细胞外信号调节激酶1和2(ERK1/2)磷酸化是通过Ras/Raf途径介导的,这一结论通过显性负性Ras突变体和药理学抑制剂得以证实。Src抑制剂4-氨基-5-甲基苯基-7-(叔丁基)吡唑并[3,4-d]嘧啶(PP1)和Rho激酶(ROCK)抑制剂N-(4-吡啶基)-4-(1-氨基乙基)环己烷甲酰胺二盐酸盐(Y27632)也减弱了SDF-1诱导的ERK1/2磷酸化。与表达Src的Src(++)细胞相比,缺乏Src/Yes/Fyn的SYF细胞中Src磷酸化及ERK1/2磷酸化缩短,这进一步证明了Src的参与。同样也能检测到RhoA的膜转位。如蛋白质免疫印迹法和共聚焦显微镜所示,在细胞核中检测到很大一部分SDF-1介导的ERK磷酸化,其导致转录因子Elk的磷酸化。有趣的是,显性负性Rho、Y27632、PP1和拉春库林B完全阻断了ERK1/2的核积累和Elk磷酸化,表明在此过程中需要Rho/ROCK途径、Src激酶和肌动蛋白细胞骨架。相应地,在用SDF-1刺激的SYF细胞中未观察到核ERK磷酸化和Elk磷酸化,但在Src(++)细胞中得以恢复。总之,这些结果表明,Src、Rho/ROCK和完整的细胞骨架有助于SDF-1刺激的细胞中ERK1/2的整体激活,并且对于ERK1/2的核转位和转录因子的激活是不可或缺的。